Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by CryoPort, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: CryoPort, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092107
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Gross margin | 22,824 | 21,377 | 44,737 | 40,018 |
| Operating costs and expenses: | ||||
| Selling, general and administrative | 28,011 | 26,908 | 55,631 | 48,809 |
| Engineering and development | 4,852 | 4,118 | 8,759 | 8,052 |
| Total operating costs and expenses | 32,863 | 31,026 | 64,390 | 56,861 |
| Loss from operations | (10,039) | (9,649) | (19,653) | (16,843) |
| Other income (expense): | ||||
| Investment income | 3,132 | 1,466 | 6,222 | 3,039 |
Cover / Front Matter
FAQ
- What is CryoPort, Inc.'s R&D?
- CryoPort, Inc. (CYRX) reported R&D of $4.85M in Q2 2026.
- How has CryoPort, Inc.'s R&D changed year-over-year?
- CryoPort, Inc.'s R&D increased by 17.8% year-over-year, from $4.12M to $4.85M.
- What is the long-term trend for CryoPort, Inc.'s R&D?
- Over 4 years (2021 to 2025), CryoPort, Inc.'s R&D has grown at a 0.3% compound annual growth rate (CAGR), from $16.84M to $17.04M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about CryoPort, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude